[1]
Tofail Ahmed et al. 2021. Role of Low Dose Overnight Dexamethasone Supression Test (Lodst) in Management Protocol for Cushing’s Syndrome. Highlights on Medicine and Medical Research Vol. 4. (Mar. 2021), 49–60. DOI:https://doi.org/10.9734/bpi/hmmr/v4/1641C.